Neuberger Berman Group LLC Opti Nose, Inc. Transaction History

Neuberger Berman Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$12.43 - $29.76 $3.86 Million - $9.25 Million	-310,924 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$18.75 - $28.46 $3.95 Million - $6 Million	210,924 Added 210.92%	310,924 $8.7 Million
Q1 2018 May 08, 2018	SELL	$15.91 - $20.82 $534,353 - $699,260	-33,586 Reduced 25.14%	100,000 $2 Million
Q4 2017 Feb 14, 2018	BUY	$15.2 - $20.76 $2.03 Million - $2.77 Million	133,586	133,586 $2.53 Million

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.